Summary: Is glucose-6-phosphatase dehydrogenase deficiency associated with severe outcomes in hospitalized COVID-19 patients?

Summary: Advanced germ cell tumors and chemotherapy in G6PD deficient patients: Yes to chemotherapy but no to rasburicase and some premedications.

Summary: Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing.

Summary: The study researched the use of Automated-red cell exchange for treating a patient with methaemoglobinaemia in G6PD deficiency.

Summary: This case report describes a 64-year-old woman who developed methemoglobinemia (blood disorder) caused by dapsone treated with dapsone discontinuation.

Summary: Rasburicase-induced haemolysis and methemoglobinemia: an ongoing issue.

Summary: Genetic spectrum and clinical early natural history of glucose-6-phosphate dehydrogenase deficiency in Mexican children detected through newborn screening.

Summary: G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?

Summary: Clinical characteristics of asymptomatic and symptomatic COVID-19 patients in the Eastern Province of Saudi Arabia.

Summary: Epidemiology, evolutionary origin, and malaria-induced positive selection effects of G6PD-deficient alleles in Chinese populations.

Summary: This study evaluated the effectiveness of single dose tafenoquine (medication used to prevent and to treat malaria; TQ) for preventing relapse in patients with plasmodium vivax malaria.

Summary: This case report discusses the treatment of severe COVID-19 infection in a patient with Glucose 6-phosphate dehydrogenase (G6PD) deficiency and additional respirator-dependent COVID-19-infected patients treated with intravenous (IV) N-acetylcysteine (NAC).